1 / 4

Urethral Stricture Treatment Market —Size, Trends, Outlook, and Opportunity Analysis, 2018 – 2026

Urethral stricture is a medical condition, which causes narrowing of the urethra due to presence of a scar tissue, tissue inflammation, infection or injury.<br>

rajbisen
Download Presentation

Urethral Stricture Treatment Market —Size, Trends, Outlook, and Opportunity Analysis, 2018 – 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Urethral Stricture Treatment Market —Size, Share, Urethral Stricture Treatment Market —Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026 Outlook, and Opportunity Analysis, 2018 – 2026 Urethral stricture is a medical condition, which causes narrowing of the urethra due to presence of a scar tissue, tissue inflammation, infection or injury. This condition can cause obstructive dysfunction of urethra with potentially serious consequences for the entire urinary tract. The urinary strictures are more common in males. They occur at any point along the urethra, but are most often seen in the bulbar region and can range from less than 1cm long to the entire length of the urethra. There are two types of urethral stricture conditions that occur in males, which include posterior and anterior urethral strictures. Download PDF Brochure Of This Research Report @ Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2381 https://www.coherentmarketinsights.com/insight/request-pdf/2381 The cause of urethral stricture depends on the site of the stricture. Some of the common causes for this condition are idiopathic, inflammatory (caused by infection or chronic inflammation in urethra, e.g., lichen sclerosus), traumatic (caused due to injury to the urethra), iatrogenic (caused by medical intervention such as endoscopic procedures, urethral catheterization, radiotherapy or surgery to neighboring organs), and congenital (caused by inherited conditions such as hypospadias and epispadias). Some of the common symptoms of urethral strictures includes painful urination, reduced urine output, incomplete emptying of the bladder, and inability to void. There are various types of treatment available for urethral strictures ranging from conservative or minimally invasive procedures to complex reconstructive procedures such as direct vision internal urethrotomy (DVIU), urethroplasty, urethral dilation, and others. Report includes chapters which deeply display the following deliverable about industry : Report includes chapters which deeply display the following deliverable about industry : • Urethral Stricture Treatment Market Research Objective and Assumption • Urethral Stricture Treatment Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Urethral Stricture Treatment Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis

  2. • Global Urethral Stricture Treatment Market, By Regions • Urethral Stricture Treatment Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Urethral Stricture Treatment Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Urethral Stricture Treatment Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Urethral Stricture Treatment Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Urethral Stricture Treatment Market - Market Dynamics Urethral Stricture Treatment Market - Market Dynamics Increasing cases of prostate cancers, injuries, and medical conditions requiring urethral stents, dilators, and catheters is one of the major factors for rise in urethral stricture cases, which in turn is driving growth of the urethral stricture treatment market. According to the National Centers for Biotechnology & Information (NCBI), urethral stricture is a common disease with prevalence of over 400 per 100,000 population among males in year 2016 globally. According to the Cancer Research UK, in males in the U.K., prostate cancer is the most common cancer with around 47,200 new cases registered in 2015. Moreover, the incidence rates of prostate cancer are projected to rise by 12% between 2014 and 2035, to 233 cases per 100,000 males by 2035 in the U.K., as per Cancer Research UK. High catheter associated urinary tract infection (CAUTI) rates of 6.8 per 1000 device days were observed in the UAE medical units in March 2015. Moreover, advancements in development of therapies for treating urethral strictures is driving growth of the urethral stricture treatment market. For instance, a Germany-based company, MukoCell GmbH developed a tissue engineering-based product called MukoCell, which is used for repair of urethral strictures and hypospadias. This product is an alternative to conventional transplantation with native buccal mucosa.

  3. However, high cost of surgical procedures and high rate of complications are some of the major factors restraining growth of the global urethral stricture treatment market. According to Healthcare Cost and Utilization Project (HCUP) 2016, the average cost of male urethroplasty can range between US$ 5,677–US$ 10,000 with an average increase of US$ 616 per year in the U.S. Urethral Stricture Treatment Market – Regional Insights Urethral Stricture Treatment Market – Regional Insights On the basis of geography, the global urethral stricture treatment market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America held dominant position in the global urethral stricture treatment market in 2017. This is owing to rising number of urethroplasties for urethral strictures in the region. Moreover, high adoption rate of innovative technologies and numerous product development is driving growth of the market. For instance, in February 2018, Urotronic, an early stage medical device company, received license for its product, Optilume drug-coated balloon (DCB), which will be used to treat urethral strictures in Canada. The development of this drug-coated ballon have a significant impact across Canada due to scarcity of physicians currently to perform majority of urethral stricture treatments. Asia Pacific is expected to witness significant growth in the urethral stricture treatment market during the forecast period, owing to improving health care infrastructure in economies such as India and China, and increasing demand for efficient treatment options for urethral strictures. Urethral Stricture Treatment Market – Competitive Landscape Urethral Stricture Treatment Market – Competitive Landscape Major players operating in the global urethral stricture treatment market include C. R. Bard, Inc., Amecath, Uromed, MedNova, Allium Medical, Surgimedik, Cook Medical Inc., Mednova, Taewoong Medical, Teleflex Incorporated, B. Braun Holding GmbH & Co. KG, Urotech, Coloplast Ltd, Boston Scientific Corporation, and Pnn Medical A/S. Key players are focusing on expanding their product portfolio, in order to retain dominant position in the market. For instance, Allium Medical, which manufactures and markets minimally invasive products, entered into the market with its product, Allium’s Ureteral Stents, which has some unique composition and better bio-compatibility. Browse Complete Report For More Information @ Browse Complete Report For More Information @ http://bit.ly/2IOM4FA http://bit.ly/2IOM4FA About Coherent Market Insights About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action- ready syndicated research reports, custom market analysis, consulting services, and competitive

  4. analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: Email: sales@coherentmarketinsights.com sales@coherentmarketinsights.com

More Related